Cryobiopsy and dye marking guided by electromagnetic navigation bronchoscopy before resection of pulmonary nodule.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
May 2022
Historique:
received: 08 08 2021
revised: 24 03 2022
accepted: 31 03 2022
pubmed: 26 4 2022
medline: 22 6 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

Our aims were to explore the feasibility, safety, and efficacy of peroperative transbronchial lung cryobiopsy (TBLC) guided by electromagnetic navigation bronchoscopy (ENB) and ENB-guided methylene blue marking of presumably non-palpable pulmonary nodules, and to assess its impact on video-assisted thoracoscopic surgery (VATS) and postoperative lung function. This approach was applied to 16 consecutive patients (Group A, mean age 64 years) who were compared retrospectively to a historical group of 49 patients (Group B, mean age 62 years) with similar nodules resected without guidance. The usefulness of dye marking was graded. The success rates of both ENB-guided TBLC and nodule localization through dye marking were computed. The type of resection, volume of resected parenchyma, duration of procedures, and postoperative lung function were compared between groups. Unpaired t-test, chi-square test, unpaired Wilcoxon test, and exact Fisher test were used when appropriate. Malignancy was pathologically proven in all patients. TBLC revealed malignancy in 9 patients in Group A. The success rate of ENB-guided dye marking was 94%. Lobectomy was less frequently performed in Group A than in Group B (p = 0.022). Forced expiratory volume in 1 s and total lung capacity were significantly less reduced in Group A than in Group B (p = 0.006 and p = 0.019, respectively). Combined procedure was longer than surgery alone (p<0.001), but its surgical part was shorter than VATS without guidance (p < 0.001). Peroperative ENB-guided TBLC with methylene blue marking of non-palpable lung nodules is feasible. A sparing lung parenchyma procedure could be achieved thanks to the ENB-guided dye marking before VATS.

Sections du résumé

BACKGROUND BACKGROUND
Our aims were to explore the feasibility, safety, and efficacy of peroperative transbronchial lung cryobiopsy (TBLC) guided by electromagnetic navigation bronchoscopy (ENB) and ENB-guided methylene blue marking of presumably non-palpable pulmonary nodules, and to assess its impact on video-assisted thoracoscopic surgery (VATS) and postoperative lung function.
METHODS METHODS
This approach was applied to 16 consecutive patients (Group A, mean age 64 years) who were compared retrospectively to a historical group of 49 patients (Group B, mean age 62 years) with similar nodules resected without guidance. The usefulness of dye marking was graded. The success rates of both ENB-guided TBLC and nodule localization through dye marking were computed. The type of resection, volume of resected parenchyma, duration of procedures, and postoperative lung function were compared between groups. Unpaired t-test, chi-square test, unpaired Wilcoxon test, and exact Fisher test were used when appropriate.
RESULTS RESULTS
Malignancy was pathologically proven in all patients. TBLC revealed malignancy in 9 patients in Group A. The success rate of ENB-guided dye marking was 94%. Lobectomy was less frequently performed in Group A than in Group B (p = 0.022). Forced expiratory volume in 1 s and total lung capacity were significantly less reduced in Group A than in Group B (p = 0.006 and p = 0.019, respectively). Combined procedure was longer than surgery alone (p<0.001), but its surgical part was shorter than VATS without guidance (p < 0.001).
CONCLUSION CONCLUSIONS
Peroperative ENB-guided TBLC with methylene blue marking of non-palpable lung nodules is feasible. A sparing lung parenchyma procedure could be achieved thanks to the ENB-guided dye marking before VATS.

Identifiants

pubmed: 35468469
pii: S2590-0412(22)00027-7
doi: 10.1016/j.resmer.2022.100911
pii:
doi:

Substances chimiques

Methylene Blue T42P99266K

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100911

Informations de copyright

Copyright © 2022 SPLF and Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of Competing Interest None.

Auteurs

Olivier Taton (O)

Department of Pneumology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium. Electronic address: Olivier.Taton@erasme.ulb.ac.be.

Youri Sokolow (Y)

Department of Thoracic Surgery, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Benjamin Bondue (B)

Department of Pneumology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Chloé Vandermeeren (C)

Department of Thoracic Surgery, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Maarten Vander Kuylen (MV)

Department of Thoracic Surgery, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Pierre Alain Gevenois (PA)

Department of Radiology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Myriam Remmelink (M)

Department of Pathology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Zita Mekinda Ngono (Z)

Department of Pneumology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Thierry Berghmans (T)

Thoracic Oncology clinic, Institut Jules Bordet, Université libre de Bruxelles (ULB), 90 Rue Meylemeersch, Brussels 1070, Belgium.

Dimitri Leduc (D)

Department of Pneumology, Hôpital Erasme, Université libre de Bruxelles (ULB), 808 Route de Lennik, Brussels 1070, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH